Critical Biologics

BiotechnologySeries ACambridge, UScriticalbiologics.com

Latest round

Series A

Last raised

Jan 2007

Total raised

$3.9M

Investors

1

About Critical Biologics

, a development stage biotechnology company, develops and commercializes diagnostics and therapeutics that predict and regulate inflammatory responses to life-threatening diseases.

Who invested in Critical Biologics

1 investor across 1 round

See all investors in Critical Biologics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 22, 2007

    Amount

    $3.9M

    Investors

    Locked

Questions about Critical Biologics

Who invested in Critical Biologics?

Critical Biologics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Critical Biologics raised?

Critical Biologics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Critical Biologics last raise money?

Critical Biologics's most recent round on record is a Series A, in Jan 2007.

What does Critical Biologics do?

, a development stage biotechnology company, develops and commercializes diagnostics and therapeutics that predict and regulate inflammatory responses to life-threatening diseases.

Where is Critical Biologics headquartered?

Critical Biologics is headquartered in Cambridge, US.

Which VCs invest in companies like Critical Biologics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Critical Biologics's stage. Their profiles are linked below.

Raising like Critical Biologics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.